Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Active albuterol or placebo, sham acupuncture, or no intervention in asthma.

Wechsler ME, Kelley JM, Boyd IO, Dutile S, Marigowda G, Kirsch I, Israel E, Kaptchuk TJ.

N Engl J Med. 2011 Jul 14;365(2):119-26. doi: 10.1056/NEJMoa1103319.

3.

Meaningful placebos--controlling the uncontrollable.

Moerman DE.

N Engl J Med. 2011 Jul 14;365(2):171-2. doi: 10.1056/NEJMe1104010. No abstract available.

PMID:
21751911
4.

Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.

Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T.

Ann Allergy Asthma Immunol. 1999 Feb;82(2):205-11.

PMID:
10071526
5.
6.

Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.

Berger WE, Milgrom H, Skoner DP, Tripp K, Parsey MV, Baumgartner RA; Xopenex Pediatric Asthma Group.

Curr Med Res Opin. 2006 Jun;22(6):1217-26.

PMID:
16846555
8.

Placebo and other interventions in asthma.

Bibalo C, Panontin E, Longo G.

N Engl J Med. 2011 Oct 13;365(15):1446; author reply 1447. doi: 10.1056/NEJMc1109235#SA2. No abstract available.

PMID:
21995395
9.

Placebo and other interventions in asthma.

Rolla G, Bucca C.

N Engl J Med. 2011 Oct 13;365(15):1446; author reply 1447. doi: 10.1056/NEJMc1109235#SA1. No abstract available.

PMID:
21995394
10.
11.

Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma.

Spector SL, Nicodemus CF, Corren J, Schanker HM, Rachelefsky GS, Katz RM, Siegel SC.

J Allergy Clin Immunol. 1995 Aug;96(2):174-81.

PMID:
7636054
12.

Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study.

Ostrom NK, Taveras H, Iverson H, Pearlman DS.

Respir Med. 2015 Nov;109(11):1410-5. doi: 10.1016/j.rmed.2015.09.004. Epub 2015 Sep 8.

13.

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.

D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.

JAMA. 1994 May 11;271(18):1412-6.

PMID:
7909853
14.

Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.

Raissy HH, Harkins M, Kelly F, Kelly HW.

Pharmacotherapy. 2008 Mar;28(3):287-94. doi: 10.1592/phco.28.3.287.

PMID:
18294107
15.

Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.

Milgrom H, Skoner DP, Bensch G, Kim KT, Claus R, Baumgartner RA; Levalbuterol Pediatric Study Group.

J Allergy Clin Immunol. 2001 Dec;108(6):938-45.

PMID:
11742271
16.

Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.

Busse WW, Casale TB, Murray JJ, Petrocella V, Cox F, Rickard K.

Am J Manag Care. 1998 Nov;4(11):1579-87.

17.
19.

Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma.

Gelb AF, Karpel J, Wise RA, Cassino C, Johnson P, Conoscenti CS.

Pulm Pharmacol Ther. 2008 Aug;21(4):630-6. doi: 10.1016/j.pupt.2008.02.005. Epub 2008 Mar 5.

PMID:
18403223
20.

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.

Chest. 1999 Sep;116(3):595-602.

PMID:
10492259

Supplemental Content

Support Center